Literature DB >> 22781782

Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative.

Candyce H Kroenke1, Bette J Caan, Marcia L Stefanick, Garnet Anderson, Robert Brzyski, Karen C Johnson, Erin LeBlanc, Cathy Lee, Andrea Z La Croix, Hannah Lui Park, Stacy T Sims, Mara Vitolins, Robert Wallace.   

Abstract

OBJECTIVE: The aim of this study was to determine whether a dietary intervention designed to reduce fat intake and increase intake of fruit, vegetables, and whole grains, and weight loss, reduces vasomotor symptoms (VMS; ie, hot flashes or night sweats) in postmenopausal women.
METHODS: We included 17,473 postmenopausal US women, ages 50 to 79 years, at baseline who participated in the Women's Health Initiative Dietary Modification trial and were not taking menopausal hormone therapy. Logistic regression was used to evaluate associations.
RESULTS: In multivariate-adjusted analyses, with simultaneous adjustment for the intervention and weight change, assignment to the dietary intervention versus the control arm was significantly (odds ratio [OR], 1.14; 95% CI, 1.01-1.28) related to a higher likelihood of symptom elimination among women with VMS at baseline. In addition, women with symptoms at baseline who lost 10 lb or more (OR, 1.23; 95% CI, 1.05-1.46) or lost 10% or more of their baseline body weight (OR, 1.56; 95% CI, 1.21-2.02) between baseline and year 1 were significantly more likely to eliminate VMS compared with those who maintained weight. Upon examining the joint effect of the dietary modification and weight loss, compared with women in the control arm who maintained weight, women who lost substantial weight (≥ 10%) as a part of the intervention (OR, 1.89; 95% CI, 1.39-2.57) but not as part of the control arm (OR, 1.40; 95% CI, 0.92-2.13) were significantly more likely to end VMS, although these two groups did not differ significantly from each other. Large weight loss (>22 lb), but not dietary changes, was related to the elimination of moderate/severe VMS.
CONCLUSIONS: Weight loss as part of a healthy dietary modification may help eliminate VMS among postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22781782      PMCID: PMC3428489          DOI: 10.1097/gme.0b013e31824f606e

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  48 in total

1.  Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?

Authors:  Gail A Greendale; Ellen B Gold
Journal:  Am J Med       Date:  2005-12-19       Impact factor: 4.965

2.  Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.

Authors:  Ellen B Gold; Alicia Colvin; Nancy Avis; Joyce Bromberger; Gail A Greendale; Lynda Powell; Barbara Sternfeld; Karen Matthews
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

3.  Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.

Authors:  Vanessa M Barnabei; Barbara B Cochrane; Aaron K Aragaki; Ingrid Nygaard; R Stan Williams; Peter G McGovern; Ronald L Young; Ellen C Wells; Mary Jo O'Sullivan; Bertha Chen; Robert Schenken; Susan R Johnson
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

4.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

Review 5.  Is this woman perimenopausal?

Authors:  Lori A Bastian; Crystal M Smith; Kavita Nanda
Journal:  JAMA       Date:  2003-02-19       Impact factor: 56.272

6.  Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.

Authors:  R E Williams; L Kalilani; D Britt DiBenedetti; X Zhou; A L Granger; S E Fehnel; K B Levine; J Jordan; R V Clark
Journal:  Climacteric       Date:  2008-02       Impact factor: 3.005

7.  Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation.

Authors:  Ellen B Gold; Gladys Block; Sybil Crawford; Laurie Lachance; Gordon FitzGerald; Heidi Miracle; Sheryl Sherman
Journal:  Am J Epidemiol       Date:  2004-06-15       Impact factor: 4.897

8.  Measuring hot flashes: summary of a National Institutes of Health workshop.

Authors:  Heather G Miller; Rose Maria Li
Journal:  Mayo Clin Proc       Date:  2004-06       Impact factor: 7.616

9.  Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women's health across the nation.

Authors:  Rebecca C Thurston; MaryFran R Sowers; Barbara Sternfeld; Ellen B Gold; Joyce Bromberger; Yuefang Chang; Hadine Joffe; Carolyn J Crandall; L Elaine Waetjen; Karen A Matthews
Journal:  Am J Epidemiol       Date:  2009-08-12       Impact factor: 4.897

10.  Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer.

Authors:  Bette J Caan; Marilyn L Kwan; Georgina Hartzell; Adrienne Castillo; Martha L Slattery; Barbara Sternfeld; Erin Weltzien
Journal:  Cancer Causes Control       Date:  2008-08-28       Impact factor: 2.506

View more
  12 in total

1.  Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study.

Authors:  Lisa Gallicchio; Susan R Miller; Judith Kiefer; Teresa Greene; Howard A Zacur; Jodi A Flaws
Journal:  J Womens Health (Larchmt)       Date:  2013-12-17       Impact factor: 2.681

2.  Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN).

Authors:  Ellen B Gold; Sybil L Crawford; Janie F Shelton; Ping G Tepper; Carolyn J Crandall; Gail A Greendale; Karen A Matthews; Rebecca C Thurston; Nancy E Avis
Journal:  Menopause       Date:  2017-01       Impact factor: 2.953

3.  Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Shrujal Baxi; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Elizabeth Kvale; Robin M Lally; Terry S Langbaum; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Deborah A Freedman-Cass; Nicole R McMillian
Journal:  J Natl Compr Canc Netw       Date:  2017-09       Impact factor: 11.908

4.  Hormone therapy use in women veterans accessing veterans health administration care: a national cross-sectional study.

Authors:  Megan R Gerber; Matthew W King; Suzanne L Pineles; Shannon Wiltsey-Stirman; Bevanne Bean-Mayberry; Sandra J Japuntich; Sally G Haskell
Journal:  J Gen Intern Med       Date:  2014-11-06       Impact factor: 5.128

5.  Fat, fit, or famished? No clear answers from the Women's Health Initiative about diet and dieting for longstanding hot flashes.

Authors:  Nancy King Reame
Journal:  Menopause       Date:  2012-09       Impact factor: 2.953

6.  Behavioral weight loss for the management of menopausal hot flashes: a pilot study.

Authors:  Rebecca C Thurston; Linda J Ewing; Carissa A Low; Aimee J Christie; Michele D Levine
Journal:  Menopause       Date:  2015-01       Impact factor: 2.953

Review 7.  Association of Mid-Life Changes in Body Size, Body Composition and Obesity Status with the Menopausal Transition.

Authors:  Carrie Karvonen-Gutierrez; Catherine Kim
Journal:  Healthcare (Basel)       Date:  2016-07-13

8.  Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?

Authors:  Eleni Leventea; Elaine F Harkness; Adam R Brentnall; Anthony Howell; D Gareth Evans; Michelle Harvie
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

9.  A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study.

Authors:  Ekta Kapoor; Stephanie Faubion; Ryan T Hurt; Karen Fischer; Darrell Schroeder; Shawn Fokken; Ivana T Croghan
Journal:  Menopause       Date:  2020-11       Impact factor: 3.310

10.  Cross-cultural comparison of perspectives on healthy eating among Chinese and American undergraduate students.

Authors:  Jinan C Banna; Betsy Gilliland; Margaret Keefe; Dongping Zheng
Journal:  BMC Public Health       Date:  2016-09-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.